154 related articles for article (PubMed ID: 7614334)
1. Dialysis-associated amyloidosis.
Drüeke T; Touam M; Zingraff J
Adv Ren Replace Ther; 1995 Jan; 2(1):24-39. PubMed ID: 7614334
[TBL] [Abstract][Full Text] [Related]
2. Serum beta 2-microglobulin concentration in dialysis patients: importance of intrinsic renal function.
McCarthy JT; Williams AW; Johnson WJ
J Lab Clin Med; 1994 Apr; 123(4):495-505. PubMed ID: 8144998
[TBL] [Abstract][Full Text] [Related]
3. Dialysis-related amyloidosis.
Manske CL
J Lab Clin Med; 1994 Apr; 123(4):458-60. PubMed ID: 8144992
[No Abstract] [Full Text] [Related]
4. Historical background and clinical treatment of dialysis-related amyloidosis.
Yamamoto S; Gejyo F
Biochim Biophys Acta; 2005 Nov; 1753(1):4-10. PubMed ID: 16226497
[TBL] [Abstract][Full Text] [Related]
5. Increase in plasma concentration of ubiquitin in dialysis patients: possible involvement in beta 2-microglobulin amyloidosis.
Okada M; Miyazaki S; Hirasawa Y
Clin Chim Acta; 1993 Nov; 220(2):135-44. PubMed ID: 8111958
[TBL] [Abstract][Full Text] [Related]
6. [Beta 2-microglobulin and dialysis-related amyloidosis].
Gejyo F
Rinsho Byori; 2001 Mar; 49(3):244-8. PubMed ID: 11307323
[TBL] [Abstract][Full Text] [Related]
7. [Amyloidosis in hemodialysis patients].
Bardin T; Zingraff J; Benoît J; Kuntz D; Drüeke T
Presse Med; 1987 May; 16(18):907-10. PubMed ID: 2954121
[TBL] [Abstract][Full Text] [Related]
8. Extraskeletal problems and amyloid.
Drüeke TB
Kidney Int Suppl; 1999 Dec; 73():S89-93. PubMed ID: 10633472
[TBL] [Abstract][Full Text] [Related]
9. Systemic involvement of dialysis-amyloidosis.
Campistol JM; Solé M; Muñoz-Gomez J; Lopez-Pedret J; Revert L
Am J Nephrol; 1990; 10(5):389-96. PubMed ID: 2080789
[TBL] [Abstract][Full Text] [Related]
10. Dialysis related amyloidosis: a disease of chronic retention and inflammation?
Floege J; Schäffer J; Koch KM; Shaldon S
Kidney Int Suppl; 1992 Oct; 38():S78-85. PubMed ID: 1405384
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis, pathogenesis, and treatment of dialysis-related amyloidosis.
Miyata T; Inagi R; Kurokawa K
Miner Electrolyte Metab; 1999; 25(1-2):114-7. PubMed ID: 10207272
[TBL] [Abstract][Full Text] [Related]
12. Pathogenetic and diagnostic aspects of dialysis-related amyloidosis.
Schaeffer J; Floege J; Ehlerding G; Koch KM
Nephrol Dial Transplant; 1995; 10 Suppl 3():4-8. PubMed ID: 7494614
[TBL] [Abstract][Full Text] [Related]
13. Dialysis-related amyloidosis.
Drüeke TB
Nephrol Dial Transplant; 1998; 13 Suppl 1():58-64. PubMed ID: 9507500
[No Abstract] [Full Text] [Related]
14. New aspects in the pathogenesis of dialysis-related amyloidosis: pathophysiology of advanced glycation end products in renal failure.
Miyata T
Nihon Jinzo Gakkai Shi; 1996 May; 38(5):191-7. PubMed ID: 8699608
[TBL] [Abstract][Full Text] [Related]
15. Pathogenesis and management of dialysis-related amyloid bone disease.
Nangaku M; Miyata T; Kurokawa K
Am J Med Sci; 1999 Jun; 317(6):410-5. PubMed ID: 10372842
[TBL] [Abstract][Full Text] [Related]
16. Dialysis amyloidosis.
Lancet; 1991 Aug; 338(8763):349-50. PubMed ID: 1677703
[No Abstract] [Full Text] [Related]
17. Beta 2-microglobulin amyloidosis: why and how to look for it.
Schaeffer J; Ehlerding G; Flöge J; Koch KM; Shaldon S
Clin Nephrol; 1995 Nov; 44 Suppl 1():S3-9. PubMed ID: 8608659
[TBL] [Abstract][Full Text] [Related]
18. Beta2-microglobulin and amyloidosis.
Drüeke TB
Nephrol Dial Transplant; 2000; 15 Suppl 1():17-24. PubMed ID: 10737162
[TBL] [Abstract][Full Text] [Related]
19. Effect of hemodialysis membranes on beta 2-microglobulin amyloidosis.
Jaradat MI; Moe SM
Semin Dial; 2001; 14(2):107-12. PubMed ID: 11264777
[TBL] [Abstract][Full Text] [Related]
20. Dialysis-associated amyloidosis.
Sethi D
Ren Fail; 1993; 15(3):349-51. PubMed ID: 8516489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
